A prospective, non-randomised phase II study of trastuzumab and capecitabine in patients with HER2 expressing advanced pancreatic cancer
Phase of Trial: Phase II
Latest Information Update: 28 Jun 2010
At a glance
- Drugs Capecitabine; Trastuzumab
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Roche
- 28 Jun 2010 Status changed from completed to discontinued according to information reported at ASCO 2010.
- 08 Jun 2010 Study information reported at ASCO 2010.
- 20 Jun 2008 New trial record.